These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
930 related items for PubMed ID: 10419542
1. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. Feelisch M, Kotsonis P, Siebe J, Clement B, Schmidt HH. Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542 [Abstract] [Full Text] [Related]
2. Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: influence of the mechanism of nitric oxide generation. Homer KL, Fiore SA, Wanstall JC. J Pharm Pharmacol; 1999 Feb; 51(2):135-9. PubMed ID: 10217311 [Abstract] [Full Text] [Related]
3. Mechanisms of relaxant activity of the nitric oxide-independent soluble guanylyl cyclase stimulator BAY 41-2272 in rat tracheal smooth muscle. Toque HA, Mónica FZ, Morganti RP, De Nucci G, Antunes E. Eur J Pharmacol; 2010 Oct 25; 645(1-3):158-64. PubMed ID: 20670622 [Abstract] [Full Text] [Related]
4. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Olesen SP, Drejer J, Axelsson O, Moldt P, Bang L, Nielsen-Kudsk JE, Busse R, Mülsch A. Br J Pharmacol; 1998 Jan 25; 123(2):299-309. PubMed ID: 9489619 [Abstract] [Full Text] [Related]
5. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation. Faraci FM, Sobey CG. Brain Res; 1999 Mar 13; 821(2):368-73. PubMed ID: 10064823 [Abstract] [Full Text] [Related]
6. Inhibition of rat platelet aggregation by the diazeniumdiolate nitric oxide donor MAHMA NONOate. Homer KL, Wanstall JC. Br J Pharmacol; 2002 Dec 13; 137(7):1071-81. PubMed ID: 12429580 [Abstract] [Full Text] [Related]
7. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darley-Usmar VM, Radomski MW, Moncada S. Proc Natl Acad Sci U S A; 1996 Feb 20; 93(4):1480-5. PubMed ID: 8643658 [Abstract] [Full Text] [Related]
8. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Sobey CG, Faraci FM. Stroke; 1997 Apr 20; 28(4):837-42; discussion 842-3. PubMed ID: 9099205 [Abstract] [Full Text] [Related]
9. Investigation of the vasorelaxant effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft. Berkan O, Bagcivan I, Kaya T, Yildirim K, Yildirim S, Doğan K. Can J Physiol Pharmacol; 2007 May 20; 85(5):521-6. PubMed ID: 17632587 [Abstract] [Full Text] [Related]
10. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation. Tseng CM, Tabrizi-Fard MA, Fung HL. J Pharmacol Exp Ther; 2000 Feb 20; 292(2):737-42. PubMed ID: 10640313 [Abstract] [Full Text] [Related]
11. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity. Galle J, Zabel U, Hübner U, Hatzelmann A, Wagner B, Wanner C, Schmidt HH. Br J Pharmacol; 1999 May 20; 127(1):195-203. PubMed ID: 10369473 [Abstract] [Full Text] [Related]
12. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide. Onoue H, Katusic ZS. Brain Res; 1998 Feb 23; 785(1):107-13. PubMed ID: 9526059 [Abstract] [Full Text] [Related]